Cargando…

Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden

INTRODUCTION: In Sweden an estimated 10,000 people with type 1 diabetes use continuous subcutaneous insulin infusion (CSII). Sensor-augmented pump therapy (SAP) is associated with higher acquisition costs but provides additional clinical benefits (e.g. reduced rate of hypoglycemic events) over and a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jendle, Johan, Smith-Palmer, Jayne, Delbaere, Alexis, de Portu, Simona, Papo, Natalie, Valentine, William, Roze, Stéphane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630551/ https://www.ncbi.nlm.nih.gov/pubmed/28871565 http://dx.doi.org/10.1007/s13300-017-0294-z

Ejemplares similares

Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands
por: Roze, Stephané, et al.
Publicado: (2019)

Analysis of Glucose Responses to Automated Insulin Suspension With Sensor-Augmented Pump Therapy
por: Ly, Trang T., et al.
Publicado: (2012)

Cost-Effectiveness of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Patients with Poorly Controlled Type 2 Diabetes in Finland
por: Roze, Stephané, et al.
Publicado: (2019)

Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia: Reduction in nocturnal hypoglycemia in those at greatest risk
por: Choudhary, Pratik, et al.
Publicado: (2011)

Effectiveness of Automated Insulin Management Features of the MiniMed(®) 640G Sensor-Augmented Insulin Pump
por: Zhong, Alex, et al.
Publicado: (2016)

Suspension of basal insulin to avoid hypoglycemia in type 1 diabetes treated with insulin pump
por: Boronat, Mauro, et al.
Publicado: (2015)

The OmniPod Insulin Management System: the latest innovation in insulin pump therapy
por: Zisser, Howard C.
Publicado: (2010)

Use of fast‐acting insulin aspart in insulin pump therapy in clinical practice
por: Evans, Mark, et al.
Publicado: (2019)

Insulin pump therapy in transient neonatal diabetes mellitus
por: Park, Joong Heum, et al.
Publicado: (2013)

Comparative study on treatment satisfaction and health perception in children and adolescents with type 1 diabetes mellitus on multiple daily injection of insulin, insulin pump and sensor-augmented pump therapy
por: Hussain, Tara, et al.
Publicado: (2017)

Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension
por: Buckingham, Bruce, et al.
Publicado: (2010)

Advantages of sensor‐augmented insulin pump therapy for pregnant women with type 1 diabetes mellitus
por: Imafuku, Hitomi, et al.
Publicado: (2023)

Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits
por: Pauley, Meghan E., et al.
Publicado: (2022)

The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study
por: Conget, Ignacio, et al.
Publicado: (2016)

Insulin Therapy with Personal Insulin Pumps and Early Angiopathy in Children with Type 1 Diabetes Mellitus
por: Tołwińska, Joanna, et al.
Publicado: (2013)

Excess weight gain during insulin pump therapy is associated with higher basal insulin doses
por: Boucher-Berry, Claudia, et al.
Publicado: (2016)

Insulin Pump Therapy Training and Management: An Opportunity for Community Pharmacists
por: Boyd, LeAnn C., et al.
Publicado: (2008)

Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age
por: Ly, Trang T., et al.
Publicado: (2018)

Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT-IPA questionnaire)
por: Messina, Rossella, et al.
Publicado: (2023)

Therapeutics of Diabetes Mellitus: Focus on Insulin Analogues and Insulin Pumps
por: Valla, Vasiliki
Publicado: (2010)

Quantitative Estimation of Insulin Sensitivity in Type 1 Diabetic Subjects Wearing a Sensor-Augmented Insulin Pump
por: Schiavon, Michele, et al.
Publicado: (2014)

Diabetes associated with dominant insulin gene mutations: outcome of 24-month, sensor-augmented insulin pump treatment
por: Ortolani, Federica, et al.
Publicado: (2015)

Insulin pump exposed to radioactive iodine
por: Magdaleno, Angela L., et al.
Publicado: (2018)

Correction to: Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT‑IPA questionnaire)
por: Messina, Rossella, et al.
Publicado: (2023)

The impact of insulin pump therapy to oxidative stress in patients with diabetic nephropathy
por: Zhang, Xing-Guang, et al.
Publicado: (2018)

Practical aspects of diabetes technology use: Continuous glucose monitors, insulin pumps, and automated insulin delivery systems
por: Marks, Brynn E., et al.
Publicado: (2021)

The durability and effectiveness of sensor-augmented insulin pump therapy in pediatric and young adult patients with type 1 diabetes
por: Lee, Yun Jeong, et al.
Publicado: (2020)

Safety of Insulin Lispro and a Biosimilar Insulin Lispro When Administered Through an Insulin Pump
por: Thrasher, James, et al.
Publicado: (2018)

First User Experiences With a Novel Touchscreen-Based Insulin Pump System in Daily Life of Patients With Type 1 Diabetes Experienced in Insulin Pump Therapy
por: Waldenmaier, Delia, et al.
Publicado: (2018)

Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy
por: Regittnig, Werner, et al.
Publicado: (2021)

“Let the Algorithm Do the Work”: Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients
por: Biester, Torben, et al.
Publicado: (2017)

SUN-151 Improved Glycemic Control with Automated Insulin Pump (AIP) Technology
por: Amole, Morolake, et al.
Publicado: (2019)

Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study
por: Steineck, Isabelle, et al.
Publicado: (2015)

Faster insulin action is associated with improved glycaemic outcomes during closed‐loop insulin delivery and sensor‐augmented pump therapy in adults with type 1 diabetes
por: Ruan, Yue, et al.
Publicado: (2017)

An Overview of Insulin Pumps and Glucose Sensors for the Generalist
por: McAdams, Brooke H., et al.
Publicado: (2016)

Insulin pumps in children - a systematic review
por: Al-Beltagi, Mohammed, et al.
Publicado: (2022)

Predicting the Optimal Basal Insulin Infusion Pattern in Children and Adolescents on Insulin Pumps
por: Holterhus, Paul-Martin, et al.
Publicado: (2013)

The relationship between different C-peptide level and insulin dose of insulin pump
por: Wei, Yihan, et al.
Publicado: (2021)

Insulin Edema With Use of U-500 Regular Insulin in a Hybrid Closed-Loop Insulin Pump
por: Vasigh, Mostafa, et al.
Publicado: (2020)

Insulin Pump Therapy Is Associated with Lower Rates of Retinopathy and Peripheral Nerve Abnormality
por: Zabeen, Bedowra, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lmthgii2b0308d37i2199s127d